• Users Online: 523
  • Print this page
  • Email this page


 
 
Table of Contents
CASE REPORT
Year : 2019  |  Volume : 12  |  Issue : 2  |  Page : 86-89

Hepatolithiasis: A case report and literature review


General Surgery Department, Rashid Hospital, Dubai, United Arab Emirates

Date of Web Publication27-Mar-2019

Correspondence Address:
Noor Amar
Rashid Hospital, Dubai
United Arab Emirates
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/HMJ.HMJ_39_18

Rights and Permissions
  Abstract 


Hepatolithiasis (HL) is defined as calculi in the biliary ducts proximal to the joining of the right and left hepatic ducts regardless of the presence of concurrent gallstones in either the gallbladder or common bile duct. Most HL cases are asymptomatic. When patients do present with symptoms, they are usually features of cholangitis. 43 year old Bengali male presented to the emergency department with signs of cholangitis and a past surgical history of recurrent cholangitis and multiple ERCPs. He was febrile with scleral icterus and right upper quadrant abdominal tenderness with a positive Murphy's sign. His labs showed and elevated white blood cell count, alkaline phosphatase, total bilirubin, and C-reactive protein. Computed tomography of the abdomen revealed multiple intrahepatic stones occluding the left hepatic biliary duct causing proximal dilation of the hepatic duct [Figure 1] and [Figure 2]. The patient was diagnosed with acute ascending cholangitis and a left hepatectomy was done. The post-operative period was uneventful. Hepatolithiasis is a rare disease found mostly in East Asia. The gold standard for its diagnosis is ERCP and PTC. The current options for treating HL include non-surgical endoscopic approaches and hepatectomy. Indications for its surgical management include presence of stones in one lobe (especially left-sided), multiple large stones that cannot be treated by other methods, complications secondary to cholangitis and suspicion of cholangiocarcinoma.

Keywords: Biliary ducts, gallstones, hepatolithiasis


How to cite this article:
Amar N, Al-Ozaibi L, Badri F. Hepatolithiasis: A case report and literature review. Hamdan Med J 2019;12:86-9

How to cite this URL:
Amar N, Al-Ozaibi L, Badri F. Hepatolithiasis: A case report and literature review. Hamdan Med J [serial online] 2019 [cited 2019 Apr 18];12:86-9. Available from: http://www.hamdanjournal.org/text.asp?2019/12/2/86/246128




  Introduction Top


Hepatolithiasis is defined as calculi in the biliary ducts proximal to the joining of the right and left hepatic ducts regardless of the presence of concurrent gallstones in either the gall bladder or common bile duct.[1] Its prevalence reaches 30%–50% in East Asia.[2]

In most cases, hepatolithiasis is asymptomatic. When patients do present with symptoms, these symptoms are usually features of cholangitis (fever, jaundice and right upper quadrant abdominal pain). Other symptoms may include chronic stomachache, abscesses and liver cirrhosis. The natural history of hepatolithiasis involves recurrent episodes of cholangitis that lead to chronic inflammatory changes and further stricture formation in the bile ducts, causing bile stasis. Hepatolithiasis is one of the known risk factors for cholangiocarcinoma. Based on several studies, the prevalence of cholangiocarcinoma in patients with hepatolithiasis ranges between 5% and 13%.[3],[4]


  Case Report Top


A 43-year-old Bengali man presented to the emergency department with right upper quadrant abdominal pain, fever, chills and jaundice of 2 days' duration. His surgical history revealed recurrent cholangitis, pancreatitis, liver abscess, cholecystectomy more than 10 years previously and multiple endoscopic retrograde cholangiopancreatographies (ERCPs), one of which was accompanied a sphincterotomy. On presentation, he was conscious, his temperature was 38°C and his blood pressure was 125/78 mmHg. He had scleral icterus and right upper quadrant abdominal tenderness with a positive Murphy's sign. Blood analysis revealed a white blood cell count of 19.5 × 109/l, alkaline phosphatase of 200 IU/l, total bilirubin of 3.8 mg/dl and C-reactive protein of 405 mg/l. Lipase (11.7 U/l) and alanine aminotransferase (90 U/l) were within normal limits. Computed tomography (CT) of the abdomen revealed multiple intrahepatic stones, with the largest occluding the left hepatic biliary duct and causing proximal dilation of the hepatic duct [Figure 1] and [Figure 2].
Figure 1: Axial pre-contrast image showing a hypodense stone in the left main hepatic duct with proximal dilation of the duct

Click here to view
Figure 2: Coronal pre-contrast image showing a hypodense stone in the left main hepatic duct with proximal dilation of the duct

Click here to view


Axial precontrast image showing a hypodense stone in the left main hepatic duct with proximal dilation of the duct.

Coronal precontrast image showing a hypodense stone in the left main hepatic duct with proximal dilation of the duct.

The patient was admitted, and acute recurrent ascending cholangitis was diagnosed. ERCP showed proximal left hepatic duct occlusion with the proximal duct dilated and filled with pus. A stent was inserted for draining the pus. Left hepatectomy was later carried out due to the presence of multiple large stones, the location of these stones and recurrent cholangitis [Figure 3]. The post-operative period was uneventful; the patient's vital signs were stable, and he was doing well. There was no longer abdominal pain or jaundice, and he was discharged 1 week later.
Figure 3: The resected left liver lobe with the stones extracted in the kidney dish

Click here to view


The resected left liver lobe with the stones extracted in the kidney dish.


  Discussion Top


The aetiology of hepatic stones is suggested to be multifactorial with diet possibly playing a larger role than ethnicity.[5] Parasitic causes have also been implicated, but the evidence is inconclusive and these causes have been suggested to be incidental.[6] Considering that the bile of patients with hepatolithiasis has an almost 100% prevalence of bacteria as opposed to the sterile bile of patients without hepatolithiasis, bacteria have also been implicated.[7] Most of these bacteria show β-glucuronidase activity (responsible for catalysing the hydrolysis of direct to indirect bilirubin). This unconjugated bilirubin is water-insoluble and combines with calcium bilirubinate to form calcium bilirubinate stones, which are the most prevalent type of stones in hepatolithiasis (80%).[8]

Bile stasis caused by many underlying hepatic diseases (such as sclerosing cholangitis or secondary to benign strictures) is another possible cause. This is proposed as the main cause of hepatolithiasis in the West.[5]

Stones are more common in the left lobe of the liver, and the reason for this is thought to be the merging of the left hepatic duct at an acute angle with the common bile duct, which tends to induce bile stasis in an already narrow biliary tree with strictures.

The diagnosis of hepatolithiasis is multimodal and similar to the process of diagnosing choledocholithiasis or cholelithiasis. Ultrasonography, contrast-enhanced CT and magnetic resonance cholangiopancreatography may all be used. However, the gold standard for therapy and diagnosis is ERCP and percutaneous transhepatic cholangiography (PTC). Carcinoembryonic antigen levels may be checked to determine the presence of concomitant cholangiocarcinoma.[3]

To decide the approach to the surgical management of hepatolithiasis, Dong's classification system is used [Table 1]. This classifies the disease based on the location of the stones and the presence of intrahepatic bile duct strictures or hepatic parenchymal atrophy.[1]
Table 1: Dong's classification, which aids the approach to surgical management of hepatolithiasis

Click here to view


Hepatolithiasis type Definition1 Localised stone disease as follows: unilobar or bilobar2 Diffuse stone disease2a, No atrophy of the hepatic parenchyma or stricture of the intrahepatic bile duct2b, segmental atrophy and/or stricture of the intrahepatic bile ducts2c, Biliary cirrhosis and portal hypertension additional type E extrahepatic stones.

The goal of managing hepatolithiasis is to break the vicious pathophysiological circle by treating ongoing infections, preventing the recurrence of cholangitis and consequent hepatic fibrosis, reducing repeated instrumentation and preventing progression to cholangiocarcinoma.

The current options for treating hepatolithiasis include nonsurgical endoscopic approaches and hepatectomy. Endoscopic management, including PTC, peroral cholangioscopy and ERCP, can be combined with extracorporeal shockwave lithotripsy – for cholesterol stones – or holmium as follows: YAG laser surgery. Although less invasive and easier to implement in most cases, a limitation to endoscopic techniques is that around 40% of patients with hepatolithiasis have strictures in the intrahepatic bile duct. This not only makes extraction of stones difficult but also does not resolve these strictures, which, in turn, causes disease recurrence. In addition, already limited access to intrahepatic stones is made more difficult by the location of these strictures, angulation of the ducts and extent of stone impaction.[2] Newer procedures include endoscopic resection of peripheral bile duct stenoses to facilitate the evacuation of intrahepatic stones and chemical bile duct embolisation. However, as the latter technique has been successfully revealed in only two patients till date, these newer approaches need to be studied for efficacy in larger numbers.[9] According to Öztürk et al.,[10] in patients with a high load of calculi, percutaneous intervention through a minimally dilated access tract is a safe and successful method of eliminating the stones.

Until 1998, surgery was the primary method for managing hepatolithiasis; however, management has since shifted to primarily nonsurgical techniques. In 2011, 66.7% of hepatolithiasis cases were treated using non-operative approaches, with the most common procedures being ERCP and stone extraction.[11] However, when comparing hepatectomy with percutaneous transhepatic cholangioscopic lithotripsy as management options for hepatolithiasis, hepatectomy was associated with a higher rate of survival (77%), a lower rate of bile duct strictures (18% vs. 58%) and a lower rate of recurrence of stones and/or cholangitis.[2],[12],[13] A lower rate of recurrence is an important risk factor as the prevalence of cholangiocarcinoma increases with recurrent hepatolithiasis.[14]

Indications for surgical management include unilobar disease, fibrosis due to recurrent cholangitis, multiple abscesses, suspicion of concurrent intrahepatic cholangiocarcinoma and disease that cannot be treated endoscopically.[15]


  Conclusion Top


Hepatolithiasis is a rare disease found mostly in East Asia. The gold standard for its diagnosis is ERCP and PTC, but the presence of concomitant cholangiocarcinoma adds considerable risk. Indications for its surgical management include the presence of stones in one liver lobe (especially the left lobe), multiple large stones that cannot be treated by other methods, complications secondary to cholangitis and suspected cholangiocarcinoma.

Consent

Written consent was obtained from both patients for the publication of this case report and accompanying images.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Feng X, Zheng S, Xia F, Ma K, Wang S, Bie P, et al. Classification and management of hepatolithiasis: A high-volume, single-center's experience. Intractable Rare Dis Res 2012;1:151-6.  Back to cited text no. 1
    
2.
Sakpal SV, Babel N, Chamberlain RS. Surgical management of hepatolithiasis. HPB (Oxford) 2009;11:194-202.  Back to cited text no. 2
    
3.
Kim HJ, Kim JS, Joo MK, Lee BJ, Kim JH, Yeon JE, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: A review. World J Gastroenterol 2015;21:13418-31.  Back to cited text no. 3
    
4.
Park HM, Hur YH, Cho CK, Koh YS, Kim HJ, Park EK, et al. Incidence of underlying biliary neoplasm in patients after major hepatectomy for preoperative benign hepatolithiasis. Ann Hepatobiliary Pancreat Surg 2016;20:173-9.  Back to cited text no. 4
    
5.
Nitin Rao AR, Chui AK. Intrahepatic stones – An etiological quagmire. Indian J Gastroenterol 2004;23:201-2.  Back to cited text no. 5
    
6.
Yellin AE, Donovan AJ. Biliary lithiasis and helminthiasis. Am J Surg 1981;142:128-36.  Back to cited text no. 6
    
7.
Sheen-Chen S, Chen W, Eng H, Sheen C, Chou F, Cheng Y, et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 2000;28:298-301.  Back to cited text no. 7
    
8.
Nakayama F. Intrahepatic stones. In: Jarnagin W, editor. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. Philadelphia: Elsevier Saunders; 1994. p. 765-74.  Back to cited text no. 8
    
9.
Li FY, Jiang LS, Cheng JQ, Mao H, Li N, Cheng NS, et al. Treatment of hepatolithiasis by chemical bile duct embolization: Report on 2 cases. Surg Laparosc Endosc Percutan Tech 2008;18:86-8.  Back to cited text no. 9
    
10.
Öztürk A, Sönmez MG, Bakdık S, Göger YE, Özkent MS, Aksoy F, et al. New surgical technique applied with urological instruments in bilobar multiple hepatolithiasis: Ultra-mini percutaneous hepatolithotomy. Turk J Urol 2017;43:371-7.  Back to cited text no. 10
    
11.
Suzuki Y, Mori T, Yokoyama M, Nakazato T, Abe N, Nakanuma Y, et al. Hepatolithiasis: Analysis of Japanese nationwide surveys over a period of 40 years. J Hepatobiliary Pancreat Sci 2014;21:617-22.  Back to cited text no. 11
    
12.
Otani K, Shimizu S, Chijiiwa K, Ogawa T, Morisaki T, Sugitani A, et al. Comparison of treatments for hepatolithiasis: Hepatic resection versus cholangioscopic lithotomy. J Am Coll Surg 1999;189:177-82.  Back to cited text no. 12
    
13.
Cheon YK, Cho YD, Moon JH, Lee JS, Shim CS. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery 2009;146:843-53.  Back to cited text no. 13
    
14.
Huang MH, Chen CH, Yang JC, Yang CC, Yeh YH, Chou DA, et al. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis. Am J Gastroenterol 2003;98:2655-62.  Back to cited text no. 14
    
15.
Li C, Wen T. Surgical management of hepatolithiasis: A minireview. Intractable Rare Dis Res 2017;6:102-5.  Back to cited text no. 15
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Introduction
Case Report
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed299    
    Printed25    
    Emailed0    
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal